Quest Diagnostics Inc. (DGX), DG FastChannel Inc. (DGIT), Webster Financial Corp. (WBS), Delek US Holding Inc. (DK), Ecolab Inc. (ECL) and Enbridge Inc. (ENB) ratings and price targets.
Piper Jaffray (NYSE:PJC) downgraded DG FastChannel Inc. (DGIT) from a “Neutral” rating to an “Underweight” rating. They have a price target of $11.00 on the company.
Jefferies (NYSE:JEF) reiterated its “Hold” rating on Quest Diagnostics Inc. (DGX). They have a price target of $61.00 on the company.
Jefferies reiterated its “Buy” on Webster Financial Corp. (WBS). They have a price target of $21.00 on the company.
Deutsche Bank (NYSE:DB) downgraded Delek US Holding Inc. (DK) from a “Buy” rating to a “Hold” rating. They have a price target of $16.00 on the company.
Jefferies raised its price target on Ecolab Inc. (ECL) to $63.00.
TD Newcrest upgraded Enbridge Inc. (ENB) from a “Hold” rating to a “Buy” rating.
Showing posts with label Quest Diagnostics. Show all posts
Showing posts with label Quest Diagnostics. Show all posts
Thursday, November 17, 2011
Tuesday, November 8, 2011
Cogent (CCOI) (ANR) (WES) (CVS) (DGX) Upgraded
Cogent Communications (NASDAQ: CCOI), Alpha Natural Resources (NYSE: ANR), Western Gas Partners (NYSE: WES), CVS Caremark (NYSE: CVS) and Quest Diagnostics Inc. (NYSE: DGX) were upgraded by analysts.
Cogent Communications (CCOI) was upgraded by DA Davidson from a “Neutral” rating to a “Buy” rating. They have a price target of $20.00 on the company.
Alpha Natural Resources (ANR) was upgraded by Howard Weil from a “Market Perform” rating to an “Outperform” rating. They have a price target of $44.00 on the company, down from $47.00.
Western Gas Partners (WES) was upgraded by Credit Suisse (NYSE:CS) from a “Neutral” rating to an “Outperform” rating.
CVS Caremark (CVS) was upgraded by RBC Capital from a “Sector Perform” rating to an “Outperform” rating. They have a price target of $44.00 on the company, up from $36.00.
Quest Diagnostics Inc. (DGX) was upgraded by RBC Capital from a “Sector Perform” rating to an “Outperform” rating. They have a price target of $68.00 on the company, up from $50.00.
Cogent Communications (CCOI) was upgraded by DA Davidson from a “Neutral” rating to a “Buy” rating. They have a price target of $20.00 on the company.
Alpha Natural Resources (ANR) was upgraded by Howard Weil from a “Market Perform” rating to an “Outperform” rating. They have a price target of $44.00 on the company, down from $47.00.
Western Gas Partners (WES) was upgraded by Credit Suisse (NYSE:CS) from a “Neutral” rating to an “Outperform” rating.
CVS Caremark (CVS) was upgraded by RBC Capital from a “Sector Perform” rating to an “Outperform” rating. They have a price target of $44.00 on the company, up from $36.00.
Quest Diagnostics Inc. (DGX) was upgraded by RBC Capital from a “Sector Perform” rating to an “Outperform” rating. They have a price target of $68.00 on the company, up from $50.00.
Thursday, August 18, 2011
EnCana (ECA) (TW) (CRIC) (DGX) (DKS) Upgraded
EnCana Co. (NYSE: ECA), Towers Watson and Co (NYSE: TW), China Real Estate Information Co. (NASDAQ: CRIC), Quest Diagnostics Inc (NYSE: DGX) and Dick’s Sporting Goods (NYSE: DKS) upgraded by analysts.
EnCana Co. (ECA) was upgraded by Ticonderoga from a “Sell” rating to a “Neutral” rating.
Towers Watson and Co. (TW) was upgraded by Stifel Nicolaus from a “Hold” rating to a “Buy” rating. They have a price target of $69.00 on the company.
China Real Estate Information Co. (CRIC) was upgraded by William Blair from a “Market Perform” rating to an “Outperform” rating.
Quest Diagnostics Inc. (DGX) was upgraded by Goldman Sachs (NYSE:GS) from a “Sell” rating to a “Neutral” rating.
Dick’s Sporting Goods (DKS) was upgraded by Sterne Agee from a “Sell” rating to a “Neutral” rating.
EnCana Co. (ECA) was upgraded by Ticonderoga from a “Sell” rating to a “Neutral” rating.
Towers Watson and Co. (TW) was upgraded by Stifel Nicolaus from a “Hold” rating to a “Buy” rating. They have a price target of $69.00 on the company.
China Real Estate Information Co. (CRIC) was upgraded by William Blair from a “Market Perform” rating to an “Outperform” rating.
Quest Diagnostics Inc. (DGX) was upgraded by Goldman Sachs (NYSE:GS) from a “Sell” rating to a “Neutral” rating.
Dick’s Sporting Goods (DKS) was upgraded by Sterne Agee from a “Sell” rating to a “Neutral” rating.
Friday, July 15, 2011
ProLogis (PLD) (AVAV) (DGX) (MDU) (SORL) (VR) All Downgraded
ProLogis (NYSE: PLD), AeroVironment (NASDAQ: AVAV), Quest Diagnostics Inc (NYSE: DGX), MDU Resources Group, Inc. (NYSE: MDU), Sorl Auto Parts, Inc. (NASDAQ: SORL) and Validus Holdings, Ltd. (NYSE: VR) downgraded by analysts.
AeroVironment (AVAV) was downgraded by Raymond James (NYSE:RJF) from an “outperform” rating to a “market perform” rating.
Quest Diagnostics (DGX) was downgraded by RBC Capital from an “outperform” rating to a “sector perform” rating. They have a price target of $61.00 on the company, down from $67.00.
MDU Resources Group, Inc. (MDU) was downgraded by Citigroup (NYSE:C) from a “buy” rating to a “hold” rating.
ProLogis (PLD) was downgraded by Jefferies (NYSE:JEF) from a “hold” rating to an “underperform” rating.
Sorl Auto Parts, Inc. (SORL) was downgraded by Oppenheimer from an “outperform” rating to a “perform” rating.
Validus Holdings, Ltd. (VR) was downgraded by Stifel Nicolaus from a “buy” rating to a “hold” rating.
AeroVironment (AVAV) was downgraded by Raymond James (NYSE:RJF) from an “outperform” rating to a “market perform” rating.
Quest Diagnostics (DGX) was downgraded by RBC Capital from an “outperform” rating to a “sector perform” rating. They have a price target of $61.00 on the company, down from $67.00.
MDU Resources Group, Inc. (MDU) was downgraded by Citigroup (NYSE:C) from a “buy” rating to a “hold” rating.
ProLogis (PLD) was downgraded by Jefferies (NYSE:JEF) from a “hold” rating to an “underperform” rating.
Sorl Auto Parts, Inc. (SORL) was downgraded by Oppenheimer from an “outperform” rating to a “perform” rating.
Validus Holdings, Ltd. (VR) was downgraded by Stifel Nicolaus from a “buy” rating to a “hold” rating.
Monday, May 2, 2011
Dividend Yields for (SYK) (UNH) (ABC) (MCK) (DGX)
Indicated dividend yields for Standard & Poor's 500 Index companies Stryker Corp (SYK), UnitedHealth Group Inc (UNH), AmerisourceBergen Corp (ABC), McKesson Corp (MCK) and Quest Diagnostics Inc (DGX).
These dividend data indicate dividend yields of companies in the Standard & Poor's 500 Index as of Saturday, April 30. The yield is determined by taking the latest declared dividend, annualized and divided by the price of the stock. Payout ratios are calculated based on latest quarterly dividend paid divided by earnings.
Stryker Corp (SYK) has a dividend yield of 1.22 percent on a declared dividend of $0.18. The payout ratio is 22.8 percent.
UnitedHealth Group Inc (UNH) has a dividend yield of 1.01 percent on a declared dividend of $0.12. The payout ratio is 10.2 percent.
AmerisourceBergen Corp (ABC) has a dividend yield of 0.98 percent on a declared dividend of $0.10. The payout ratio is 12.8 percent.
McKesson Corp (MCK) has a dividend yield of 0.87 percent on a declared dividend of $0.18. The payout ratio is 29.5 percent.
Quest Diagnostics Inc (DGX) has a dividend yield of 0.71 percent on a declared dividend of $0.10. The payout ratio is 11.4 percent.
These dividend data indicate dividend yields of companies in the Standard & Poor's 500 Index as of Saturday, April 30. The yield is determined by taking the latest declared dividend, annualized and divided by the price of the stock. Payout ratios are calculated based on latest quarterly dividend paid divided by earnings.
Stryker Corp (SYK) has a dividend yield of 1.22 percent on a declared dividend of $0.18. The payout ratio is 22.8 percent.
UnitedHealth Group Inc (UNH) has a dividend yield of 1.01 percent on a declared dividend of $0.12. The payout ratio is 10.2 percent.
AmerisourceBergen Corp (ABC) has a dividend yield of 0.98 percent on a declared dividend of $0.10. The payout ratio is 12.8 percent.
McKesson Corp (MCK) has a dividend yield of 0.87 percent on a declared dividend of $0.18. The payout ratio is 29.5 percent.
Quest Diagnostics Inc (DGX) has a dividend yield of 0.71 percent on a declared dividend of $0.10. The payout ratio is 11.4 percent.
Thursday, April 21, 2011
Quest Diagnostics (DGX) PT Raised on Stronger Volumes
Quest Diagnostics (NYSE:DGX) had its price target raised on it by Kaufman Brothers, citing an improvement in volume at the company.
Kaufman says that, "volume is a leading indicator that Quest is not only retaining its current volume base, but with somewhat spotty reports on the physician office visit front, that it could also be seeing the early signs of "traction" with its specialized sales initiative that could lead to some mild market share gains. Pricing softness disappointed us. Importantly, there is "visibility" on improvement, as contract discounts are set to anniversary in 2H11."
Kaufman Bros. is cutting its full year 2011 EPS estimate from $4.55 to $4.37 and is maintaining its full year 2012 estimate of $4.95. It also raised its full year 2011 revenue by 1 percent to $7,532.9 million.
Quest was trading at $56.71, falling $1.15, or 1.99 percent, as of 2:25 PM EDT. Kaufman maintains a "Buy" rating on Quest Diagnostics, while increasing its price target from $64 to $69.
Kaufman says that, "volume is a leading indicator that Quest is not only retaining its current volume base, but with somewhat spotty reports on the physician office visit front, that it could also be seeing the early signs of "traction" with its specialized sales initiative that could lead to some mild market share gains. Pricing softness disappointed us. Importantly, there is "visibility" on improvement, as contract discounts are set to anniversary in 2H11."
Kaufman Bros. is cutting its full year 2011 EPS estimate from $4.55 to $4.37 and is maintaining its full year 2012 estimate of $4.95. It also raised its full year 2011 revenue by 1 percent to $7,532.9 million.
Quest was trading at $56.71, falling $1.15, or 1.99 percent, as of 2:25 PM EDT. Kaufman maintains a "Buy" rating on Quest Diagnostics, while increasing its price target from $64 to $69.
Subscribe to:
Posts (Atom)